Drugs for solid cancer: the productivity crisis prompts a rethink
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F13%3A10191696" target="_blank" >RIV/00216208:11310/13:10191696 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.2147/OTT.S45177" target="_blank" >http://dx.doi.org/10.2147/OTT.S45177</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2147/OTT.S45177" target="_blank" >10.2147/OTT.S45177</a>
Alternative languages
Result language
angličtina
Original language name
Drugs for solid cancer: the productivity crisis prompts a rethink
Original language description
Despite remarkable progress in cancer-drug discovery, the delivery of novel, safe, and sustainably effective products to the clinic has stalled. Using Src as a model, we examine key steps in drug development. The preclinical evidence on the relationshipbetween Src and solid cancer is in sharp contrast with the modest anticancer effect noted in conventional clinical trials. Here, we consider Src inhibitors as an example of a promising drug class directed to invasion and metastasis and identify roadblocks in translation. We question the assumption that a drug-induced tumor shrinkage in preclinical and clinical studies predicts a successful outcome. Our analysis indicates that the key areas requiring attention are related, and include preclinical models(in vitro and mouse models), meaningful clinical trial end points, and an appreciation of the role of metastasis in morbidity and mortality. Current regulations do not reflect the natural history of the disease, and may be unrelated to th
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
OncoTargets and Therapy
ISSN
1178-6930
e-ISSN
—
Volume of the periodical
6
Issue of the periodical within the volume
June
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
767-777
UT code for WoS article
000320915800001
EID of the result in the Scopus database
—